Preferred Label : Stimulants drug panel:-:Pt:Urine:-:Screen;
LOINC status : ACTIVE;
LOINC display name : Stimulants drug panel Screen (U);
LOINC long common name : Stimulants drug panel - Urine by Screen method;
LOINC short name : Stimulants drug panel Ur Scn;
LOINC description : This panel aides in the determination of compliance or identify illicit stimulant
drug use. The panel detects stimulants which stimulate the central nervous system
activity and, in part, suppress the appetite. Amphetamine and methamphetamine are
also prescription drugs used in the treatment of narcolepsy and attention-deficit
disorder/attention-deficit hyperactivity disorder (ADHD). Methylphenidate is another
stimulant used to treat ADHD. Phentermine is indicated for the management of obesity.
All of the other amphetamines (e.g., methylenedioxymethamphetamine: MDMA) are Drug
Enforcement Administration (DEA) scheduled Class I compounds. Physiological symptoms
associated with very high amounts of ingested amphetamine or methamphetamine include
elevated blood pressure, dilated pupils, hyperthermia, convulsions, and acute amphetamine
psychosis. If a stimulant or its corresponding metabolite is identified (present),
it indicates that the patient has used the respective stimulant in the recent past
(typically 1-3 days). The absence of the expected stimulant or its metabolites may
indicate noncompliance, inappropriate timing of specimen collection relative to drug
administration, poor drug absorption, diluted or adulterated urine, or limitations
of testing. The concentration of the drug must be greater than or equal to the cutoff
to be reported as present.;
Origin ID : 99107-5;
UMLS CUI : C5570172;
Has component
- Has method
- Has system
- Has time aspect
- Panel of LOINC codes
- Semantic type(s)
